Shared on04 Aug 25Fair value Increased 6.90%
Analysts raised their price target for Performant Healthcare to $7.75, citing its leading role in healthcare payment integrity, favorable momentum from its new New York Medicaid contract, and confidence in its scalable, diversified business model. Analyst Commentary Recognition of Performant as a leading technology-enabled healthcare payment integrity vendor.
Shared on24 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Increased 0.55%
AnalystConsensusTarget has increased revenue growth from 7.9% to 9.7%, decreased profit margin from 4.6% to 3.5%, increased future PE multiple from 91.5x to 120.6x and increased shares outstanding growth rate from 0.0% to 0.0%.